Moderna Inc.

News & Events

Press Releases

In The Media

1. Moderna to Report Second Quarter 2025 Financial Results on Friday, August 1, 2025

   ACCESS Newswire JUL 11, 2025 7:00 AM EDT
   CAMBRIDGE, MA / ACCESS Newswire / July 11, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced ...
   READ ARTICLE

2. Moderna Receives Full U.S. FDA Approval for COVID-19 Vaccine, Spikevax, in Children Aged 6 Months Through 11 Years at Increased Risk for COVID-19 Disease

   ACCESS Newswire JUL 10, 2025 8:00 AM EDT
   Spikevax is now approved for all adults aged 65 years and older, and individuals aged 6 months th...
   READ ARTICLE

3. Moderna Announces Positive Phase 3 Results for Seasonal Influenza Vaccine

   ACCESS Newswire JUN 30, 2025 7:00 AM EDT
   mRNA-1010 demonstrated superior relative vaccine efficacy that was 26.6% (95% CI; 16.7%, 35.4%) h...
   READ ARTICLE

4. Moderna Receives U.S. FDA Approval for RSV Vaccine, mRESVIA, in Adults Aged 18-59 at Increased Risk for RSV Disease

   ACCESS Newswire JUN 12, 2025 7:25 PM EDT
   Expanded indication builds on existing U.S. FDA approval of mRESVIA for adults aged 60 and older ...
   READ ARTICLE

5. Moderna to Present at Upcoming Barclays Speaking the Science Call Series on June 16, 2025

   ACCESS Newswire JUN 11, 2025 7:00 AM EDT
   CAMBRIDGE, MA / ACCESS Newswire / June 11, 2025 / Moderna, Inc. (Nasdaq:MRNA), today announced...
   READ ARTICLE

6. Moderna Receives U.S. FDA Approval for COVID-19 Vaccine mNEXSPIKE

   ACCESS Newswire MAY 31, 2025 12:16 AM EDT
   mNEXSPIKE becomes Moderna's third FDA-approved product CAMBRIDGE, MA / ACCESS Newswire / M...
   READ ARTICLE

7. Moderna Announces Update on Investigational Pandemic Influenza Program

   ACCESS Newswire MAY 28, 2025 6:00 PM EDT
   Phase 1/2 H5 avian flu vaccine study shows positive interim results Company has been notifie...
   READ ARTICLE

8. Moderna to Present at Upcoming Conferences in June 2025

   ACCESS Newswire MAY 27, 2025 7:00 AM EDT
   CAMBRIDGE, MA / ACCESS Newswire / May 27, 2025 / Moderna, Inc. (Nasdaq:MRNA), today announced ...
   READ ARTICLE

9. Moderna Files FDA Application for the LP.8.1 Targeting COVID-19 Vaccine

   ACCESS Newswire MAY 23, 2025 4:05 PM EDT
   CAMBRIDGE, MA / ACCESS Newswire / May 23, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced t...
   READ ARTICLE

10. Moderna Provides Update on BLA Submission for Combination Vaccine Against Influenza and COVID-19

    ACCESS Newswire MAY 21, 2025 7:00 AM EDT
    CAMBRIDGE, MA / ACCESS Newswire / May 21, 2025 / Moderna, Inc. (Nasdaq:MRNA), today announced ...
    READ ARTICLE